{
  "ticker": "NVO",
  "name": "Novo Nordisk A/S",
  "price": 51.32,
  "market_cap": 228039376896,
  "revenue_ttm": 49695390308.231316,
  "net_income_ttm": 16340274770.696375,
  "ocf_ttm": 19491241191.9852,
  "capex_ttm": 9893949533.519663,
  "sbc_ttm": 0.0,
  "buyback_ttm": 1398102586.3087037,
  "total_debt": 15937330236.586231,
  "cash_and_equivalents": 5130575128.921782,
  "book_value_ttm": 26752115891.823803,
  "shares_outstanding": 3368607341,
  "beta": 1.2,
  "roe": 71.47,
  "analyst_growth_estimate": 5.1,
  "forward_eps": 3.4545546,
  "dividend_yield": 336.0,
  "sector_type": "BioTech",
  "currency_code": "USD",
  "last_updated": "2025-12-30T18:30:30Z"
}